Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Monreal M, Bertoletti L, Lopez-Nunez JJ, Tiberio G, et al. TEMPORARY REMOVAL: OC-14: Effectiveness and safety of 6-months' treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study. Thromb Res 2022;213 Suppl 2:S8-S9.
PMID: 35643715


Privacy Policy